<DOC>
	<DOC>NCT01312636</DOC>
	<brief_summary>This study is conducted in Japan. The aim of this observational study is to evaluate the long-term safety and efficacy of activated recombinant human factor VII (NovoSeven®) in subjects with congenital FVII deficiency.</brief_summary>
	<brief_title>Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Congenital FVII deficiency Never been treated with NovoSeven® before Patients already in treatment with NovoSeven® History of hypersensitivity to any of the components in NovoSeven®</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>